Page last updated: 2024-08-21

hydrazine and 22q11.2 Deletion Syndrome

hydrazine has been researched along with 22q11.2 Deletion Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Frączkiewicz, J; Kazanowska, B; Sęga-Pondel, D; Ussowicz, M	1

Other Studies

1 other study(ies) available for hydrazine and 22q11.2 Deletion Syndrome

Article	Year
Eltrombopag Therapy in Children With Rare Disorders Associated With Thrombocytopenia. Journal of pediatric hematology/oncology, 2020, Volume: 42, Issue:2 Topics: Acyl-CoA Dehydrogenase, Long-Chain; Adolescent; Benzoates; Child; Child, Preschool; Congenital Bone Marrow Failure Syndromes; DiGeorge Syndrome; Female; Graft Rejection; Hematopoietic Stem Cell Transplantation; Humans; Hydrazines; Lipid Metabolism, Inborn Errors; Male; Mitochondrial Diseases; Muscular Diseases; Prognosis; Pyrazoles; Receptors, Thrombopoietin; Thrombocytopenia; Wiskott-Aldrich Syndrome	2020

Article

Year

Eltrombopag Therapy in Children With Rare Disorders Associated With Thrombocytopenia.

Journal of pediatric hematology/oncology, 2020, Volume: 42, Issue:2

Topics: Acyl-CoA Dehydrogenase, Long-Chain; Adolescent; Benzoates; Child; Child, Preschool; Congenital Bone Marrow Failure Syndromes; DiGeorge Syndrome; Female; Graft Rejection; Hematopoietic Stem Cell Transplantation; Humans; Hydrazines; Lipid Metabolism, Inborn Errors; Male; Mitochondrial Diseases; Muscular Diseases; Prognosis; Pyrazoles; Receptors, Thrombopoietin; Thrombocytopenia; Wiskott-Aldrich Syndrome

2020